The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-5-(2-(7-Nitro-4-oxo-3,4-dihydrothieno[3,2-d]pyrimidin-2-yl)vinyl)furan-2-carboxylic Acid ID: ALA4541208
PubChem CID: 155551259
Max Phase: Preclinical
Molecular Formula: C13H7N3O6S
Molecular Weight: 333.28
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1ccc(/C=C/c2nc3c([N+](=O)[O-])csc3c(=O)[nH]2)o1
Standard InChI: InChI=1S/C13H7N3O6S/c17-12-11-10(7(5-23-11)16(20)21)14-9(15-12)4-2-6-1-3-8(22-6)13(18)19/h1-5H,(H,18,19)(H,14,15,17)/b4-2+
Standard InChI Key: JNBUPKZSCNZUGC-DUXPYHPUSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
3.4502 -28.6459 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1660 -28.2367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1672 -27.4115 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4526 -26.9956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4526 -26.1784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7401 -28.2346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7408 -27.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9571 -27.1549 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.4719 -27.8214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9560 -28.4886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8726 -28.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5814 -28.2406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7017 -29.2702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2480 -29.8779 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9022 -29.4394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2880 -28.6512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3754 -29.4612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1743 -29.6334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5849 -28.9268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0397 -28.3181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3978 -28.8436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8763 -29.5060 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7322 -28.0980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7 4 1 0
6 1 1 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
2 11 1 0
11 12 2 0
13 14 2 0
13 15 1 0
10 13 1 0
12 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 1 0
19 21 1 0
21 22 1 0
21 23 2 0
M CHG 2 13 1 15 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 333.28Molecular Weight (Monoisotopic): 333.0056AlogP: 2.35#Rotatable Bonds: 4Polar Surface Area: 139.33Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.14CX Basic pKa: ┄CX LogP: 1.62CX LogD: -1.84Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.55Np Likeness Score: -1.01
References 1. Shao X, AbdelKhalek A, Abutaleb NS, Velagapudi UK, Yoganathan S, Seleem MN, Talele TT.. (2019) Chemical Space Exploration around Thieno[3,2-d ]pyrimidin-4(3H )-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors., 62 (21): [PMID:31584822 ] [10.1021/acs.jmedchem.9b01198 ]